ReviewFrontiers in immunology2026
Association between combined allergic rhinitis and asthma syndrome in children and nitric oxide: mechanisms, clinical significance, and research progress.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Combined Allergic Rhinitis and Asthma Syndrome (CARAS) in children is a chronic airway inflammatory disorder with a high prevalence in childhood. In recent years, a growing body of studies has identified a close association between fractional exhaled nitric oxide (FeNO) and nasal exhaled nitric oxide (nNO) and the pathogenesis of CARAS in children. By synthesizing relevant literature retrieved from the PubMed database (1985-2025), this article provides an in-depth analysis of the roles of the NO/cyclic guanosine monophosphate (cGMP) signaling pathway, nitrosative stress, and organelle injury in the pathogenesis of CARAS in children. Meanwhile, it reviews the potential clinical significance of exhaled nitric oxide as a non-invasive biomarker in supporting the diagnosis and therapeutic monitoring of CARAS in children, analyzes the latest research advances and existing controversies, and outlines future research directions, thereby providing a theoretical basis for the optimized clinical management of this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.